AU2974300A - Plasminogen kringle 4 region fragments and methods of use - Google Patents

Plasminogen kringle 4 region fragments and methods of use

Info

Publication number
AU2974300A
AU2974300A AU29743/00A AU2974300A AU2974300A AU 2974300 A AU2974300 A AU 2974300A AU 29743/00 A AU29743/00 A AU 29743/00A AU 2974300 A AU2974300 A AU 2974300A AU 2974300 A AU2974300 A AU 2974300A
Authority
AU
Australia
Prior art keywords
methods
region fragments
plasminogen kringle
kringle
plasminogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29743/00A
Inventor
M. Judah Folkman
Michael S O'reilly
Yuen W. Shing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Publication of AU2974300A publication Critical patent/AU2974300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU29743/00A 1999-01-28 2000-01-26 Plasminogen kringle 4 region fragments and methods of use Abandoned AU2974300A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11761799P 1999-01-28 1999-01-28
US60117617 1999-01-28
US37071999A 1999-08-09 1999-08-09
US09370719 1999-08-09
PCT/US2000/002091 WO2000044391A2 (en) 1999-01-28 2000-01-26 Plasminogen kringle 4 region fragments and methods of use

Publications (1)

Publication Number Publication Date
AU2974300A true AU2974300A (en) 2000-08-18

Family

ID=26815458

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29743/00A Abandoned AU2974300A (en) 1999-01-28 2000-01-26 Plasminogen kringle 4 region fragments and methods of use

Country Status (5)

Country Link
EP (1) EP1147202A2 (en)
JP (1) JP2002535372A (en)
AU (1) AU2974300A (en)
CA (1) CA2360690A1 (en)
WO (1) WO2000044391A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003517007A (en) * 1999-12-15 2003-05-20 エントレメッド インコーポレイテッド Endothelial cell growth inhibiting compositions and methods
US20020159992A1 (en) * 2000-09-29 2002-10-31 Jack Henkin Antiangiogenic polypeptides and methods for inhibiting angiogenesis
CA3008686C (en) 2015-12-18 2023-03-14 Talengen International Limited Method for preventing and treating diabetic nephropathy
CN106890324A (en) * 2015-12-18 2017-06-27 深圳瑞健生命科学研究院有限公司 A kind of method for preventing and treating diabetic nephropathy
TWI763680B (en) 2016-12-15 2022-05-11 大陸商深圳瑞健生命科學硏究院有限公司 Use of plasminogen in preparing medicine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945403A (en) * 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
MX9605109A (en) * 1994-04-26 1997-08-30 Childrens Medical Center Angiostatin and method of use for inhibition of angiogenesis.
ATE368051T1 (en) * 1995-04-26 2007-08-15 Childrens Medical Center ANGIOSTATIN FRAGMENTS AND METHODS OF USE THEREOF

Also Published As

Publication number Publication date
EP1147202A2 (en) 2001-10-24
JP2002535372A (en) 2002-10-22
WO2000044391A2 (en) 2000-08-03
WO2000044391A3 (en) 2000-12-21
CA2360690A1 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2001253411A1 (en) Medical dressing assembly and associated method of using the same
GB2353810B (en) Cutting elements and methods of manufacture thereof
AU7339800A (en) Ophthalmic device and method of manufacture and use
AU2468401A (en) Underreamer and method of use
AU2002213838A1 (en) Method of producing non-bovine chymosin and use thereof
AU3622600A (en) Metalloproteinases and methods of use therefor
AU715620C (en) Therapeutic methods and uses
AU5679899A (en) Reduction of surfactant inactivation in pulmonary surfactant therapy
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AU3065999A (en) Compositions and methods for treatment of asthma
AU3951995A (en) Urokinase plasminogen activator fragments
AU2974300A (en) Plasminogen kringle 4 region fragments and methods of use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU2584699A (en) Immediate early genes and methods of use therefor
AU5144299A (en) Production and use of modified cystatins
AU3863900A (en) Prolyl peptidases and methods of use
GB9912994D0 (en) Fibrin fragments and therapeutic targets
AU4364200A (en) Quilted foam pad and method of making same from scrap foam
SG90719A1 (en) Novel therapeutic and prophylactic agents and methods of using same
AU1330301A (en) Canelo products and methods of making and using same
AU2002227119A1 (en) Nonwoven material and method of manufacture therefor
AU2001261785A1 (en) Vdup1 promoter and methods of use thereof
AU4259496A (en) Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases
AU2279601A (en) Npr1-interactors and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase